Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Grant/Award of 6,300 AKTX shares, $49.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Akari Therapeutics Plc (AKTX) | Grant/Award | 6,300 | $49.8K |
| Jul 17, 2026 | Akari Therapeutics Plc (AKTX) | Exercise/Conversion | 1,209 | $9.7K |
| Dec 19, 2025 | Akari Therapeutics Plc (AKTX) | Purchase | 618,658 | n/a |
| Mar 24, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 175,000 | n/a |
| Mar 10, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 406,250 | $455.0K |
| Jan 7, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 208,000 | $124.80 |
| Dec 30, 2024 | Akari Therapeutics Plc (AKTX) | Grant/Award | 3,200,000 | $1.6K |
| Dec 27, 2024 | Akari Therapeutics Plc (AKTX) | Grant/Award | 7,500,000 | $3.8K |
| Dec 26, 2024 | Akari Therapeutics Plc (AKTX) | Grant/Award | 1,400,000 | $700.00 |
| Dec 26, 2024 | Akari Therapeutics Plc (AKTX) | Grant/Award | 1,400,000 | $700.00 |